Interval-training and Appetite Regulation in Patients With Type 2 Diabetes
NCT ID: NCT02592616
Last Updated: 2016-06-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
14 participants
INTERVENTIONAL
2015-10-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will assess if IW leads to greater exercise-induced suppression of appetite and ad libitum food intake compared to CW and no exercise.
Subjects with type 2 diabetes will be included in a crossover, counter-balanced, controlled study, where each subject will undergo three trials. Trials will be identical except the following interventions:
1. One hour of rest (CON)
2. One hour of interval walking (repeated cycles of 3 min of fast and 3 min of slow walking; IW)
3. One hour of continuous walking (CW) matched to IW with regards to energy-expenditure.
After the interventions subjects will undergo a liquid mixed meal tolerance test (450 kCal), with regular measurements of appetite-related hormones (insulin, ghrelin, Leptin, Cholecystokinin, PYY). Three hours into the mixed meal tolerance test, a standardised ad-libitum meal test will be served and intake will recorded. Free-living energy intake via food records will be assessed during the following 32 hours.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimization of Interval-training in Patients With Type 2 Diabetes
NCT02601482
The Features Behind the Beneficial Effects of Interval-walking
NCT02257190
Interval-training in Type 2 Diabetics
NCT02320526
The Acute Effect of Interval-walking
NCT01987258
Exercise Training and Type 2 Diabetes
NCT01234155
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CON
Control (CON).
CON
No exercise intervention.
CW
Continuous Walking (CW).
CW
One hour of continuous walking on a treadmill.
IW
Interval Walking (IW).
IW
One hour of interval (repeated cycles of 3 minutes of fast and 3 minutes of slow) walking on treadmill.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CON
No exercise intervention.
CW
One hour of continuous walking on a treadmill.
IW
One hour of interval (repeated cycles of 3 minutes of fast and 3 minutes of slow) walking on treadmill.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI \> 25
Exclusion Criteria
* Smoking
* Contraindication to increased levels of physical activity
* Eating disorder
* Insulin dependence
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anders Rasmussen Rinnov
MD, PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Physical Activity Research (CFAS)
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-15008542
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.